Senda Biosciences Revenue, Growth & Competitor Profile

DBA KINTAI THERAPEUTICS INC

Company Profile & Annual Report for Senda Biosciences

Access the complete profile.

Senda Biosciences Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	20 Acorn Park Dr Cambridge, MA 02140

Note: Revenues for privately held companies are statistical evaluations.


Senda Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Senda Biosciences's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Senda Biosciences is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Senda Biosciences Annual Revenue and Growth Rate

Senda Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Senda Biosciences's revenues are gauged from an analysis of company filings.

Senda Biosciences's Income Statement (based on Industry Averages)

Senda Biosciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Senda Biosciences is developing and marketing. Senda Biosciences doesn't have any recent trademark applications, indicating Senda Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
S Therapeutic products in the nature of pharmaceuticals to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical agents that modulate metabolism for scientific and research use	03/16/2022
VIASOME Pharmaceuticals; therapeutics; Pharmaceutical preparations comprised of plant and microbial particles and extracts; lipid nanoparticles for use in drug delivery systems, biotechnology, life sciences, clinical sample preparation; drug delivery systems that include nanoparticles; nanoparticles; lipid nanoparticles	11/09/2021
X-VIASOME Pharmaceuticals; therapeutics; pharmaceutical preparations for the treatment of cancer, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, and immunological diseases and disorders; pharmaceutical preparations comprised of plant and microbial particles and extracts	11/09/2021

See all trademarks and details in the Full Report.

Market Share of Senda Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Senda Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Senda Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Future Competition: Senda Biosciences's Fastest Growing Competitors

These companies are in the same general field as Senda Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)